KPV is the C-terminal tripeptide of alpha-melanocyte-stimulating hormone. It reduces NF-κB activation and pro-inflammatory cytokine release in epithelial and immune cells, with the strongest evidence in models of intestinal inflammation (Dalmasso et al., Gastroenterology 2008).
Chosen for gut and systemic inflammation protocols, and as a component of the KLOW combination.
Presentation
Format: Pre-filled injection pen
Strength: 15mg / 2ml
Storage: refrigerate at 2–8 °C; keep away from light
Supplied to healthcare professionals and their patients for use under medical supervision. Product information is educational and does not replace clinical judgement.
